When.com Web Search

  1. Ads

    related to: inhaler brand and generic names of insulin for sale

Search results

  1. Results From The WOW.Com Content Network
  2. Inhalable insulin - Wikipedia

    en.wikipedia.org/wiki/Inhalable_insulin

    In general, inhaled insulins have been more rapidly absorbed than subcutaneous injected insulin, with faster peak concentration in serum and more rapid metabolism. [ 2 ] Exubera , developed by Inhale Therapeutics (later named Nektar Therapeutics ), became the first inhaled insulin product to be marketed, in 2006 by Pfizer , [ 3 ] but poor sales ...

  3. List of medical inhalants - Wikipedia

    en.wikipedia.org/wiki/List_of_medical_inhalants

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file

  4. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    Currently, inhaled insulin is short-acting and is typically taken before meals; an injection of long-acting insulin at night is often still required. [110] When people were switched from injected to inhaled insulin, no significant difference was observed in Hb A1c levels over three months. Accurate dosing was a particular problem, although ...

  5. Yes, the price of an inhaler in the US is massively higher ...

    www.aol.com/yes-price-inhaler-us-massively...

    One international pharmaceutical company charges $489 for brand name inhaler Combivent Respimat ... that there is very little generic competition. "Brand-name manufacturers have erected large ...

  6. Fact check: Yes, the price of an inhaler in the U.S. is ... - AOL

    www.aol.com/fact-check-yes-price-inhaler...

    “Big drug companies charge as little as $7 for an inhaler overseas and nearly $500 for the exact same one here in the US,” Baldwin said Feb. 1, 2024 in a Facebook post.. “That has got to end.

  7. Fast-acting, inhaled insulin Afrezza approved by F.D.A. - AOL

    www.aol.com/article/2014/06/29/fast-acting...

    The U.S. Food and Drug Administration has approved a fast-acting diabetes drug called Afrezza for use by adults with Type 1 or Type 2 diabetes. The drug is inhaled into the lungs using a small ...